Comparison of Perioperative Outcome Between Monopolar and Bipolar Hysteroscopic Myomectomy

Last updated: July 6, 2023
Sponsor: Far Eastern Memorial Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Bipolar hysteroscopic myomectomy

Monopolar hysteroscopic myomectomy

Clinical Study ID

NCT05423925
111121-E
  • Ages > 20
  • Female

Study Summary

Objective:

To evaluate clinical outcome between monopolar and bipolar hysteroscopic myomectomy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • women who received hysteroscopic myomectomy between July 2008 and April 2022 will bereviewed.

Exclusion

Exclusion Criteria:

  • < 20 years old women
  • Cervical fibroids were excluded.

Study Design

Total Participants: 250
Treatment Group(s): 2
Primary Treatment: Bipolar hysteroscopic myomectomy
Phase:
Study Start date:
June 07, 2022
Estimated Completion Date:
December 31, 2023

Study Description

Methods:

Hysteoscopic myomectomy is a safe and effective procedure to remove submucosal myoma. Distension media is needed to distend the uterine cavity during the procedure. The electric cutting loops included monopolar and bipolar electrodes, and have their corresponding distension media. Medical records, including outpatient and inpatient records, operation note, and laboratory data, of all consecutive women who received hysteroscopic myomectomy between July 2008 and April 2022 will be reviewed.

Expected result: The investigatorscan get the differences between monopolar and bipolar hysteroscopic myomectomy, and the result can be used as a reference in clinical practice.

Connect with a study center

  • Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital

    Banqiao, New Taipei 22050
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.